Adjunctive Diagnosis of Mycobacterium gordonae Pneumonia by Metagenomic Next-Generation Sequencing in an Immunocompetent Patient: A Case Report and Literature Review
Shengqiao Shi,Wei Gai,Hui Huang,Yafeng Zheng,Xiaojing Zhang,Yuanrong Dai,Chengyun Wu
DOI: https://doi.org/10.2147/idr.s494310
2024-12-10
Infection and Drug Resistance
Abstract:Shengqiao Shi, 1, &ast Wei Gai, 2, &ast Hui Huang, 1 Yafeng Zheng, 2 Xiaojing Zhang, 2, 3 Yuanrong Dai, 1 Chengyun Wu 1 1 Department of Respiratory Medicine, The 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China; 2 WillingMed Technology (Beijing) Co., Ltd, Beijing, People's Republic of China; 3 CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chengyun Wu; Yuanrong Dai, Department of Respiratory Medicine, The 2nd Affiliated Hospital of Wenzhou Medical University, No. 109, College West Road, Wenzhou, Zhejiang, 325027, People's Republic of China, Email ; Introduction: Mycobacterium gordonae is a nonpathogenic pathogen commonly found in nature and is generally considered a contaminant in clinical practice. Although there have been few reported cases of infection, most of them are secondary to immunosuppression. This paper described a rare case of globular shadow in the chest of an immunocompetent male who was diagnosed with M. gordonae pulmonary disease. He went to the hospital with chest pains that had lasted for more than two weeks. The routine clinical pathogen detection failed to discover the cause of the infection. Although metagenomic next-generation sequencing (mNGS) of the lung tissue was negative, M. gordonae was detected in the background microorganism with only one read. Based on the pathological results, it was considered to be the causative pathogen. Two months of treatment with rifampicin, ethambutol, clarithromycin, and levofloxacin resulted in significant reduction and absorption of lung lesions. No abnormalities were detected in either lung one year later. The lack of positive culture and other conventional microbiological test results make this case is not a strictly confirmed case. This study also explored the clinical features and treatment options of 32 cases of M. gordonae pulmonary disease through a systematic review of the literature. Although there is no standard recommended treatment regimen for M. gordonae infection, but combination therapy with macrolides, rifampicin, and ethambutol has been proven effective. Conclusion: This case highlights that when the clinical highly suspected of infection, mNGS can contribute to the early identification of non-tuberculous Mycobacterium (NTM) even with low reads, when clinical suspicion is high. Analyzing background microorganisms in sterile samples may help diagnose rare pathogens. Keywords: Mycobacterium gordonae , globular shadow, pulmonary disease, nontuberculous mycobacterium, mNGS Mycobacterium gordonae is a non-tuberculous Mycobacterium (NTM) that grows chronically and belongs to Runyon type II dark chromogenic bacteria. 1 It is widely found in natural environments such as water, soil, and unpasteurized milk. Although it is one of the least virulent NTM and generally non-pathogenic, it is more commonly found in hospital water supply systems. Nosocomial pseudoinfections have been reported, and the isolation and culture of this bacterium in laboratory specimens is generally considered to be contamination. 2,3 Currently, the diagnosis of NTM is predominantly based on acid-fast stain (AFS) and culture. 4 The cell wall of NTM has a high lipid content, which makes it suitable for acid-fast staining. Nevertheless, the sensitivity of staining can be influenced by various factors, including pathogen abundance and sample processing methods. Moreover, clinical symptoms and acid-fast bacilli (AFB) positive sputum smear or culture cannot accurately differentiate between Mycobacterium tuberculosis (MTB) infection, NTM infection, or NTM environmental contamination. 5 Culture continues to be one of the most sensitive methods for detecting NTM. However, problems such as low positive rate and long culture period cannot achieve early diagnosis. 4 T-SPOT can distinguish PTB from NTM-PD. 6–9 However, in clinical practice, the positive rate of T-SPOT in patients with NTM-PD is close to 30%, especially in countries with high TB burden, and the ability of T-SPOT to distinguish patients with NTM-PD from patients with PTB is limited. 9 GeneXpert Mycobacterium tuberculosis /rifampicin (MTB/RIF) is a conceptually helpful tool for establishing TB disease. Current research suggests that NTM will not cause false positives in GeneXpert, therefore, the presence of NTM is indicated by negative GeneXpert and positive smear m -Abstract Truncated-
pharmacology & pharmacy,infectious diseases